VIDEO: Seladelpar improves markers of cholestasis in primary biliary cholangitis

video seladelpar improves markers of cholestasis in primary biliary cholangitis

Sumary of VIDEO: Seladelpar improves markers of cholestasis in primary biliary cholangitis:

  • November 14, 2021 1 min watch Source/Disclosures Published by: Source: Mayo M.
  • Back to Healio In a video exclusive, Marlyn Mayo, MD, of the University of Texas Southwestern Medical Center, reported long-term treatment with seladelpar was safe and well-tolerated in reducing markers of cholestasis and hepatocellular injury.

Want to know more click here go to source.

From -

Close

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close